Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been given a consensus recommendation of “Buy” by the seven analysts that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 […]
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been given a consensus recommendation of “Buy” by the seven analysts that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 […]
